vs
Clarus Corp（CLAR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Clarus Corp的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.8倍（$65.4M vs $35.5M），Clarus Corp净利率更高（-47.8% vs -304.2%，领先256.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -8.4%），Clarus Corp自由现金流更多（$11.6M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -2.9%）
Clarus Corp是一家全球性企业，主营高性能户外休闲、登山、露营及生活方式产品的设计、生产与分销，旗下拥有多个知名消费品牌，为北美、欧洲及亚太地区的户外爱好者、专业运动员和零售合作伙伴提供创新耐用的运动装备。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CLAR vs RXRX — 直观对比
营收规模更大
CLAR
是对方的1.8倍
$35.5M
营收增速更快
RXRX
高出690.1%
-8.4%
净利率更高
CLAR
高出256.5%
-304.2%
自由现金流更多
CLAR
多$58.9M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-2.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $65.4M | $35.5M |
| 净利润 | $-31.3M | $-108.1M |
| 毛利率 | 27.7% | 59.8% |
| 营业利润率 | -59.6% | -304.8% |
| 净利率 | -47.8% | -304.2% |
| 营收同比 | -8.4% | 681.7% |
| 净利润同比 | 52.3% | 39.6% |
| 每股收益（稀释后） | $-0.81 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLARRXRX
| Q4 25 | $65.4M | $35.5M | ||
| Q3 25 | $69.3M | $5.2M | ||
| Q2 25 | $55.2M | $19.2M | ||
| Q1 25 | $60.4M | $14.7M | ||
| Q4 24 | $71.4M | $4.5M | ||
| Q3 24 | $67.1M | $26.1M | ||
| Q2 24 | $56.5M | $14.4M | ||
| Q1 24 | $69.3M | $13.8M |
净利润CLARRXRX
| Q4 25 | $-31.3M | $-108.1M | ||
| Q3 25 | $-1.6M | $-162.3M | ||
| Q2 25 | $-8.4M | $-171.9M | ||
| Q1 25 | $-5.2M | $-202.5M | ||
| Q4 24 | $-65.5M | $-178.9M | ||
| Q3 24 | $-3.2M | $-95.8M | ||
| Q2 24 | $-5.5M | $-97.5M | ||
| Q1 24 | $21.9M | $-91.4M |
毛利率CLARRXRX
| Q4 25 | 27.7% | 59.8% | ||
| Q3 25 | 35.1% | -183.8% | ||
| Q2 25 | 35.6% | -4.9% | ||
| Q1 25 | 34.4% | -48.0% | ||
| Q4 24 | 33.4% | -181.4% | ||
| Q3 24 | 35.0% | 53.7% | ||
| Q2 24 | 36.1% | 36.2% | ||
| Q1 24 | 35.9% | 19.1% |
营业利润率CLARRXRX
| Q4 25 | -59.6% | -304.8% | ||
| Q3 25 | -4.4% | -3327.6% | ||
| Q2 25 | -19.7% | -916.8% | ||
| Q1 25 | -11.2% | -1297.9% | ||
| Q4 24 | -70.2% | -4042.4% | ||
| Q3 24 | -8.0% | -377.1% | ||
| Q2 24 | -14.4% | -697.4% | ||
| Q1 24 | -9.8% | -698.4% |
净利率CLARRXRX
| Q4 25 | -47.8% | -304.2% | ||
| Q3 25 | -2.3% | -3135.3% | ||
| Q2 25 | -15.3% | -894.2% | ||
| Q1 25 | -8.7% | -1373.3% | ||
| Q4 24 | -91.8% | -3935.5% | ||
| Q3 24 | -4.7% | -367.5% | ||
| Q2 24 | -9.7% | -676.6% | ||
| Q1 24 | 31.6% | -662.4% |
每股收益（稀释后）CLARRXRX
| Q4 25 | $-0.81 | $-0.17 | ||
| Q3 25 | $-0.04 | $-0.36 | ||
| Q2 25 | $-0.22 | $-0.41 | ||
| Q1 25 | $-0.14 | $-0.50 | ||
| Q4 24 | $-1.72 | $-0.56 | ||
| Q3 24 | $-0.08 | $-0.34 | ||
| Q2 24 | $-0.14 | $-0.40 | ||
| Q1 24 | $0.57 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.7M | $743.3M |
| 总债务越低越好 | $0 | $9.6M |
| 股东权益账面价值 | $196.4M | $1.1B |
| 总资产 | $249.0M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资CLARRXRX
| Q4 25 | $36.7M | $743.3M | ||
| Q3 25 | $29.5M | $659.8M | ||
| Q2 25 | $28.5M | $525.1M | ||
| Q1 25 | $41.3M | $500.5M | ||
| Q4 24 | $45.4M | $594.4M | ||
| Q3 24 | $36.4M | $427.6M | ||
| Q2 24 | $46.2M | $474.3M | ||
| Q1 24 | $47.5M | $296.3M |
总债务CLARRXRX
| Q4 25 | $0 | $9.6M | ||
| Q3 25 | $2.0M | $11.9M | ||
| Q2 25 | $1.9M | $14.2M | ||
| Q1 25 | $1.9M | $16.4M | ||
| Q4 24 | $1.9M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | $37.0K | — |
股东权益CLARRXRX
| Q4 25 | $196.4M | $1.1B | ||
| Q3 25 | $225.8M | $1.0B | ||
| Q2 25 | $225.1M | $919.1M | ||
| Q1 25 | $229.3M | $933.9M | ||
| Q4 24 | $233.1M | $1.0B | ||
| Q3 24 | $308.5M | $524.6M | ||
| Q2 24 | $307.3M | $584.4M | ||
| Q1 24 | $310.4M | $401.2M |
总资产CLARRXRX
| Q4 25 | $249.0M | $1.5B | ||
| Q3 25 | $283.1M | $1.4B | ||
| Q2 25 | $286.5M | $1.3B | ||
| Q1 25 | $292.8M | $1.3B | ||
| Q4 24 | $294.1M | $1.4B | ||
| Q3 24 | $375.3M | $726.5M | ||
| Q2 24 | $369.4M | $775.9M | ||
| Q1 24 | $377.0M | $557.8M |
负债/权益比CLARRXRX
| Q4 25 | 0.00× | 0.01× | ||
| Q3 25 | 0.01× | 0.01× | ||
| Q2 25 | 0.01× | 0.02× | ||
| Q1 25 | 0.01× | 0.02× | ||
| Q4 24 | 0.01× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.5M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | 17.7% | -133.1% |
| 资本支出强度资本支出/营收 | 1.4% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.9M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流CLARRXRX
| Q4 25 | $12.5M | $-46.1M | ||
| Q3 25 | $-5.7M | $-117.4M | ||
| Q2 25 | $-9.4M | $-76.4M | ||
| Q1 25 | $-2.1M | $-132.0M | ||
| Q4 24 | $16.6M | $-115.4M | ||
| Q3 24 | $-8.3M | $-59.2M | ||
| Q2 24 | $834.0K | $-82.2M | ||
| Q1 24 | $-16.4M | $-102.3M |
自由现金流CLARRXRX
| Q4 25 | $11.6M | $-47.3M | ||
| Q3 25 | $-7.0M | $-117.6M | ||
| Q2 25 | $-11.3M | $-79.6M | ||
| Q1 25 | $-3.3M | $-133.8M | ||
| Q4 24 | $14.4M | $-116.7M | ||
| Q3 24 | $-9.4M | $-63.8M | ||
| Q2 24 | $-744.0K | $-83.4M | ||
| Q1 24 | $-18.3M | $-109.0M |
自由现金流率CLARRXRX
| Q4 25 | 17.7% | -133.1% | ||
| Q3 25 | -10.0% | -2272.5% | ||
| Q2 25 | -20.4% | -413.9% | ||
| Q1 25 | -5.4% | -907.4% | ||
| Q4 24 | 20.1% | -2567.7% | ||
| Q3 24 | -14.0% | -244.6% | ||
| Q2 24 | -1.3% | -578.5% | ||
| Q1 24 | -26.3% | -789.9% |
资本支出强度CLARRXRX
| Q4 25 | 1.4% | 3.5% | ||
| Q3 25 | 1.8% | 4.7% | ||
| Q2 25 | 3.4% | 16.4% | ||
| Q1 25 | 2.0% | 12.4% | ||
| Q4 24 | 3.1% | 28.6% | ||
| Q3 24 | 1.6% | 17.5% | ||
| Q2 24 | 2.8% | 8.2% | ||
| Q1 24 | 2.7% | 48.2% |
现金转化率CLARRXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
RXRX
暂无分部数据
